The invention relates to the technical field of providing nutritional therapeutic composition, comprising of pea protein concentrate, blended with known quantities of sprouted bean powders obtained from soya bean, mung bean and sprouted seeds of fenugreek, based on the evidence based nutrition principles and recommendations for the prevention, control and effective management of diabetes and other metabolic related disorders. Diabetes is a not a curable disease and the first line of therapy in type-2 diabetes is nutritional management, which has been recently referred to as niedical nutrition therapy therefore, the goals of our sprout based medical nutrition therapy to diabetics is to increase their intake of natural, unrefined form of sprout nutrients capable of enhancing the bodys ability to metabolize glucose and insulin,maintenance of near-normal blood glucose levels naturally by balancing food nutrition and blood glucose regulation, achievement of optimal serum lipid levels and blood pressure, provision of adequate calories for maintaining ideal weight, prevention and treatment of complications, and improvement in overall health. Therefore, the great demand in the market for an unrefined natural food aimed at the diabetic population, in which all its content, and not only the glucose component, will be beneficial for said population could be achieved through this invention.
